{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:34:02Z","timestamp":1792794842900,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.vaccine.2024.06.053","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T12:52:29Z","timestamp":1720615949000},"page":"126086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Typhoid conjugate vaccine perceptions and coverage among children and adults: Findings from a post-campaign coverage survey \u2013 Harare, Zimbabwe, 2019"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0702-5628","authenticated-orcid":false,"given":"Radhika","family":"Gharpure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0259-4634","authenticated-orcid":false,"given":"Ashley T.","family":"Longley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7792-2500","authenticated-orcid":false,"given":"Mayuko","family":"Takamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hidle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9239-9690","authenticated-orcid":false,"given":"Manes","family":"Munyanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trymore","family":"Chawurura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mamire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Chaora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9348-0573","authenticated-orcid":false,"given":"Jethro","family":"Chakauya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Rupfutse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6953-0056","authenticated-orcid":false,"given":"Marc","family":"Poncin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Gasasira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashmira","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Portia","family":"Manangazira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Sreenivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.06.053_b0005","unstructured":"Institute for Health Metrics and Evaluation. Typhoid fever\u2013level 4 cause. Seattle, WA: Institute for Health Metrics and Evaluation, Global Burden of Disease Collaborative Network; 2020."},{"key":"10.1016\/j.vaccine.2024.06.053_b0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.053_b0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4114-0","article-title":"Laboratory characterisation of Salmonella enterica serotype Typhi isolates from Zimbabwe, 2009\u20132017","volume":"19","author":"Mashe","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.053_b0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4269\/ajtmh.18-0111","article-title":"Typhoid fever: way forward","volume":"99","author":"Bhutta","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2024.06.053_b0025","doi-asserted-by":"crossref","first-page":"S781","DOI":"10.1093\/infdis\/jiab449","article-title":"Typhoid conjugate vaccines: advancing the research and public health agendas","volume":"224","author":"Birkhold","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.053_b0030","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1093\/cid\/ciy884","article-title":"Overview of the typhoid conjugate vaccine pipeline: current status and future plans","volume":"68","author":"Sahastrabuddhe","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.053_b0035","unstructured":"World Health Organization. Department of immunization, vaccines and biologicals (IVB). Background paper to SAGE: update on typhoid vaccines. Switzerland: World Health Organization Geneva; 2022."},{"key":"10.1016\/j.vaccine.2024.06.053_b0040","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1473-3099(18)30804-1","article-title":"Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study","volume":"19","author":"Bilcke","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.053_b0045","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.vaccine.2022.12.032","article-title":"Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness","volume":"41","author":"Burrows","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.053_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08105-2","article-title":"Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study","volume":"23","author":"Phillips","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.053_b0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijid.2021.05.061","article-title":"Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: a randomized controlled phase 2 trial","volume":"108","author":"Sirima","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.053_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(18)30087-2","article-title":"Typhoid conjugate vaccine gets WHO prequalification","volume":"18","author":"Burki","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.053_b0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018 - recommendations","volume":"37","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.053_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114702","article-title":"Descriptive epidemiology of typhoid fever during an epidemic in Harare, Zimbabwe, 2012","volume":"9","author":"Polonsky","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.06.053_b0075","doi-asserted-by":"crossref","first-page":"342","DOI":"10.15585\/mmwr.mm6711a7","article-title":"Notes from the field: typhoid fever outbreak - Harare, Zimbabwe, October 2016\u2013March 2017","volume":"67","author":"Davis","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.06.053_b0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.15585\/mmwr.mm6802a5","article-title":"Notes from the field: typhoid fever outbreak - Harare, Zimbabwe, October 2017\u2013February 2018","volume":"68","author":"N'Cho","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.06.053_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2022.100201","article-title":"Implementation of an outbreak response vaccination campaign with typhoid conjugate vaccine - Harare, Zimbabwe, 2019","volume":"12","author":"Poncin","year":"2022","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2024.06.053_b0090","series-title":"World Health Organization vaccination coverage cluster surveys: reference manual","year":"2018"},{"key":"10.1016\/j.vaccine.2024.06.053_b0095","unstructured":"Council for International Organizations of Medical Sciences. Definition and application of terms for vaccine pharmacovigilance. Report of CIOMS\/WHO Working Group on Vaccine Pharmacovigilance; 2012."},{"key":"10.1016\/j.vaccine.2024.06.053_b0100","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.vaccine.2022.04.098","article-title":"Enhanced surveillance for adverse events following immunization during the 2019 typhoid conjugate vaccine campaign in Harare, Zimbabwe","volume":"40","author":"Shaum","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.053_b0105","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/j.vaccine.2016.06.053","article-title":"Monitoring vaccination coverage: defining the role of surveys","volume":"34","author":"Cutts","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.053_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(21)00311-6","article-title":"Zimbabwe tackles typhoid and cholera through vaccination","volume":"2","author":"Bagcchi","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2024.06.053_b0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.15585\/mmwr.mm7207a2","article-title":"Typhoid fever surveillance, incidence estimates, and progress toward typhoid conjugate vaccine introduction - worldwide, 2018\u20132022","volume":"72","author":"Hancuh","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.06.053_b0120","unstructured":"UNICEF. MICS-EAGLE Zimbabwe education fact sheets; 2021."},{"key":"10.1016\/j.vaccine.2024.06.053_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000101","article-title":"Nationwide introduction of HPV vaccine in Zimbabwe 2018\u20132019: experiences with multiple cohort vaccination delivery","volume":"2","author":"Carlton","year":"2022","journal-title":"PLOS Glob Public Health"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2024.06.053_b0130","doi-asserted-by":"crossref","first-page":"A58","DOI":"10.1016\/j.vaccine.2021.07.012","article-title":"HPV vaccination coverage in three districts in Zimbabwe following national introduction of 0,12 month schedule among 10 to 14 year old girls","volume":"40","author":"LaMontagne","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.053_b0135","unstructured":"Oberman E. Typhoid conjugate vaccine arrives in Zimbabwe, 2021. Coalition against typhoid; 2021."},{"key":"10.1016\/j.vaccine.2024.06.053_b0140","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2016.24.47.8663","article-title":"Vaccine receipt and vaccine card availability among children of the apostolic faith: analysis from the 2010\u20132011 Zimbabwe demographic and health survey","volume":"24","author":"Kriss","year":"2016","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.vaccine.2024.06.053_b0145","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s10943-017-0428-7","article-title":"Qualitative assessment of vaccination hesitancy among members of the apostolic church of Zimbabwe: a case study","volume":"56","author":"Machekanyanga","year":"2017","journal-title":"J Relig Health"},{"key":"10.1016\/j.vaccine.2024.06.053_b0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.15585\/mmwr.mm6917a3","article-title":"Notes from the field: cholera outbreak - Zimbabwe, September 2018\u2013March 2019","volume":"69","author":"Winstead","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.06.053_b0155","series-title":"Digital documentation of COVID-19 certificates: vaccination status: technical specifications and implementation guidance, 27 August 2021","year":"2021"},{"key":"10.1016\/j.vaccine.2024.06.053_b0160","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/ofid\/ofad042","article-title":"Progress in the typhoid conjugate vaccine program rollout supported by Gavi During the COVID-19 pandemic and the path forward","volume":"10","author":"Russell","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.053_b0165","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1016\/j.vaccine.2022.04.093","article-title":"Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: a matched case control study","volume":"40","author":"Lightowler","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.053_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(19)30425-6","article-title":"Typhoid Vi-conjugate vaccine for outbreak control in Zimbabwe","volume":"19","author":"Olaru","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T17:48:00Z","timestamp":1729014480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24007278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":34,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0264410X24007278"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Typhoid conjugate vaccine perceptions and coverage among children and adults: Findings from a post-campaign coverage survey \u2013 Harare, Zimbabwe, 2019","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126086"}}